Interventional Radiology Imaging

Recurrent Lower GI Bleed After Colonoscopy: Why Is Arteriography the Next Step?

·
Recurrent Lower GI Bleed After Colonoscopy: Why Is Arteriography the Next Step?

It’s 2 AM, and you get a call from the intensive care unit. Your 72-year-old patient, who underwent colonoscopy yesterday for hematochezia where a bleeding diverticulum was clipped, has just had another large-volume, bright red bowel movement. His hemoglobin is dropping, and his blood pressure is soft. The gastroenterology team feels they have exhausted their endoscopic options. You need to decide on the next, definitive step to control the hemorrhage. This article provides a clinical workflow for this exact scenario: ongoing or recurrent lower gastrointestinal bleeding after a localized, attempted endoscopic treatment. According to the American College of Radiology (ACR) Appropriateness Criteria, the next intervention, Transcatheter arteriography/embolization, is Usually appropriate.

Who Fits This Clinical Scenario?

This guidance applies to a specific and challenging patient population: those with lower gastrointestinal (GI) bleeding where the source has already been localized by colonoscopy, but endoscopic therapy was either unsuccessful or the bleeding has recurred. The key inclusion criteria are a known bleeding site (e.g., a specific colonic segment identified endoscopically) and evidence of continued or recurrent hemorrhage requiring further intervention.

It is crucial to distinguish this situation from other related presentations. This workflow does not apply to:

  • Hemodynamically unstable patients with massive, active bleeding: These patients often require a different initial algorithm, potentially involving emergent surgery or proceeding directly to angiography without a preceding CTA, as detailed in the ACR variant for unstable lower GI bleeding.
  • Obscure or nonlocalized GI bleeding: If colonoscopy and upper endoscopy fail to identify a source in a stable patient, the workup shifts toward different modalities like capsule endoscopy or deep enteroscopy, which are covered in a separate ACR scenario.
  • Initial presentation of lower GI bleeding: For a patient presenting for the first time with hematochezia who has not yet had a colonoscopy, the initial diagnostic steps are different.

This article is exclusively for the “next step” after a known source proves difficult to manage endoscopically.

What Diagnoses Are You Working Up in This Scenario?

In this context, the location of the bleed is known, but the underlying cause and reason for refractory bleeding are the focus. The differential remains centered on the most common etiologies of lower GI bleeding, with the added complexity of failed primary treatment.

Diverticular Hemorrhage: This is the most common cause of major lower GI bleeding. The bleeding is typically arterial, arising from the vasa recta stretched over the dome of a diverticulum. Endoscopic clipping or thermal therapy can fail if the vessel retracts, the clip dislodges, or the view is obscured by blood, making it a frequent reason for escalation to interventional radiology.

Angiodysplasia (Arteriovenous Malformation): These dilated, tortuous submucosal vessels are a common source of bleeding, especially in older adults. They can be challenging to treat endoscopically with thermal coagulation, and re-bleeding is common. Their vascular nature makes them an ideal target for superselective embolization.

Post-Polypectomy Bleeding: This can occur immediately or be delayed by days to weeks. Bleeding from the stalk or base of a resected polyp is typically arterial. While often controlled endoscopically, persistent bleeding from a larger vessel within the stalk may necessitate angiographic intervention.

Less Common Causes: While less frequent, refractory bleeding from colonic malignancies, ischemic colitis, or inflammatory bowel disease (IBD) can also present this way. In these cases, angiography serves to stabilize the patient, acting as a bridge to definitive surgical or medical management.

Why Is Transcatheter Arteriography/Embolization the Recommended Study for This Presentation?

When endoscopic treatment for a localized lower GI bleed fails, the clinical priority shifts from localization to definitive hemostasis. Transcatheter arteriography with embolization is rated Usually appropriate because it uniquely combines high-resolution diagnosis with immediate therapeutic capability in a single procedure.

The primary advantage of this approach is its ability to directly visualize the bleeding artery via catheter-based angiography and then stop the hemorrhage by deploying embolic agents (like microcoils or particles) into the vessel. This is highly effective for the common arterial causes of lower GI bleeding, such as diverticulosis and angiodysplasia. The procedure can be performed with high technical success rates, often obviating the need for more invasive surgery.

Let’s consider the alternatives and why they are rated lower in this specific scenario:

  • Computed Tomography Angiography (CTA): Rated May be appropriate (Disagreement), CTA is an excellent diagnostic tool for localizing active bleeding. However, in this scenario, the site is already known from colonoscopy. While a pre-procedure CTA can provide a vascular roadmap for the interventionalist, its role is less critical, and it adds time, cost, and a significant radiation dose (☢☢☢☢ 10-30 mSv). Some institutions proceed directly to angiography if the bleeding site is confidently localized.
  • Repeat Colonoscopy: Also rated May be appropriate (Disagreement), a second attempt at endoscopic therapy may be considered. However, if the initial attempt failed due to technical difficulty or the nature of the bleeding lesion, a repeat procedure is less likely to succeed and delays more definitive treatment.
  • Surgery: Rated May be appropriate, surgery (typically a segmental colectomy) is definitive but carries significant morbidity and mortality, especially in elderly, comorbid patients who are actively bleeding. It is generally reserved for cases where interventional radiology is unavailable, fails, or is contraindicated.

While the target vessels for lower GI bleeding differ, our protocol guide on embolization techniques, such as Uterine Artery Embolization (UAE), covers the fundamental principles of catheterization, contrast use, and embolic agent selection that are broadly applicable to interventional procedures.

What’s Next After Transcatheter Arteriography/Embolization? Downstream Workflow

The patient’s clinical course following transcatheter arteriography/embolization depends on the procedural outcome. The downstream decision tree is relatively straightforward.

If the procedure is successful (bleeding vessel identified and embolized): The patient should be monitored closely in a high-acuity setting (ICU or step-down unit) for signs of re-bleeding (e.g., further hematochezia, hemodynamic instability, dropping hemoglobin) or complications like non-target embolization leading to bowel ischemia (e.g., abdominal pain, fever, elevated lactate). If the patient remains stable, they can gradually advance their diet and be managed for their underlying conditions. The vast majority of patients with successful embolization will not require further acute intervention.

If the procedure is technically unsuccessful (bleeding vessel not identified): This can occur if the bleeding is intermittent or has temporarily stopped. In this “negative” angiogram, the patient should still be monitored closely. If bleeding recurs, options include a repeat angiogram if the patient is unstable or, if stable, considering provocative angiography (using vasodilators or anticoagulants to unmask the bleeding site, though this is controversial and carries risk). If bleeding remains occult, the workup may pivot to that of an obscure GI bleed.

If embolization fails to control the bleeding or re-bleeding occurs: This is a critical juncture. The immediate next step is consultation with colorectal surgery. The patient may require an emergent segmental colectomy. The prior localization from both colonoscopy and angiography is invaluable in this situation, allowing for a targeted surgical resection rather than a subtotal colectomy.

Pitfalls to Avoid (and When to Get Help)

Navigating this clinical scenario requires careful coordination and awareness of potential missteps. Here are a few common pitfalls to avoid:

  • Delaying the Call to Interventional Radiology: Time is critical. Once endoscopic therapy has clearly failed, prolonged attempts at medical resuscitation without a definitive plan can lead to increased transfusion requirements and worsening coagulopathy, making any subsequent intervention more difficult.
  • Inadequate Resuscitation: The patient must be adequately resuscitated with blood products and fluids before and during transfer to the angiography suite. An interventional procedure cannot succeed in a patient who is profoundly hypotensive or coagulopathic.
  • Misinterpreting Vasospasm: Sometimes, catheter manipulation can induce vasospasm at the bleeding site, which can be mistaken for successful hemostasis on angiography. A careful angiographer will wait or use vasodilators to ensure there is no underlying active bleed before concluding the study.

If there is any evidence of bowel ischemia post-embolization (severe pain, peritoneal signs, rising lactate), escalate immediately with an urgent surgical consultation.

Related ACR Topics and Tools

For a comprehensive overview of all clinical variants and imaging modalities in this domain, please consult our parent guide. For help with other scenarios or calculating radiation dose, the following tools are available.

Frequently Asked Questions

Should I order a CTA before sending the patient for transcatheter arteriography?

According to the ACR, a CTA is rated ‘May be appropriate (Disagreement)’ in this scenario. Because the bleeding site has already been localized by colonoscopy, a CTA is not always necessary and primarily serves as a vascular roadmap for the interventional radiologist. Many institutions will proceed directly to the angiography suite to save time, particularly if the patient is actively bleeding. The decision often depends on institutional protocol and interventionalist preference.

What is the risk of bowel ischemia after embolization for a lower GI bleed?

The risk of clinically significant bowel ischemia after superselective embolization is low, generally reported to be in the single digits. The colon has a rich collateral blood supply. The risk increases with more proximal embolization (e.g., embolizing a main colic artery trunk instead of a terminal vessel), in patients with pre-existing vascular disease, or after previous abdominal surgery that may have disrupted collateral pathways. Patients must be monitored closely for post-procedure pain, fever, and rising lactate.

What if the angiogram is negative and doesn’t show any active bleeding?

A negative angiogram can occur if the bleeding is intermittent and has temporarily paused. If the patient is stable, they should be monitored closely for signs of re-bleeding. If bleeding recurs, a repeat angiogram may be positive. In some cases, a tagged red blood cell (RBC) scan may be considered to confirm active bleeding before a repeat procedure, though RBC scans are rated ‘Usually not appropriate’ in this primary scenario by the ACR.

Why isn’t surgery the first choice after a failed colonoscopy?

While surgery is definitive, it is rated ‘May be appropriate’ because it is associated with significantly higher morbidity and mortality compared to minimally invasive embolization, especially in an emergent setting for an unstable patient. Transcatheter embolization offers a highly effective, less invasive alternative that can control the bleeding and avoid a major operation. Surgery is typically reserved as the next step if embolization fails or is not available.

Can this procedure be performed on a patient who is on anticoagulants?

Yes, but the patient’s coagulopathy must be corrected as much as possible before the procedure. This often involves reversing anticoagulation and transfusing platelets or fresh frozen plasma (FFP) to target an INR <1.5 and a platelet count >50,000/μL. The interventional radiologist should be made aware of the patient’s anticoagulation status to plan for appropriate reversal and management of access site hemostasis.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026